These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1775970)

  • 1. Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy.
    Bonadonna G; Valagussa P; Brambilla C; Moliterni A; Zambetti M; Ferrari L
    Semin Oncol; 1991 Dec; 18(6):515-24. PubMed ID: 1775970
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant therapy in breast cancer.
    Robert NJ
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):693-707. PubMed ID: 7731642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the ATF (low dose adriamycin + tamoxifen + tegafur) therapy as adjuvant chemotherapy of breast cancer].
    Nishizawa Y; Koyama H; Noguchi S; Miyauchi K; Terasawa T
    Nihon Gan Chiryo Gakkai Shi; 1988 Mar; 23(3):728-33. PubMed ID: 3136218
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant therapy for breast cancer: understanding the overview. International Breast Cancer Study Group.
    Gelber RD; Goldhirsch A; Coates AS
    J Clin Oncol; 1993 Mar; 11(3):580-5. PubMed ID: 8445434
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
    Brito RA; Valero V; Buzdar AU; Booser DJ; Ames F; Strom E; Ross M; Theriault RL; Frye D; Kau SW; Asmar L; McNeese M; Singletary SE; Hortobagyi GN
    J Clin Oncol; 2001 Feb; 19(3):628-33. PubMed ID: 11157012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials referral resource. Adjuvant therapy of breast cancer.
    Cheson BD
    Oncology (Williston Park); 1989 Jun; 3(6):70-1, 74-5, 78. PubMed ID: 2534915
    [No Abstract]   [Full Text] [Related]  

  • 7. Old and new trends in the adjuvant treatment of early breast cancer.
    Goldhirsch A; Valagussa P
    Ann Oncol; 1991 May; 2(5):320-2. PubMed ID: 1954175
    [No Abstract]   [Full Text] [Related]  

  • 8. Doxorubicin as adjuvant therapy for breast cancer: answers or more questions?
    Carbone PP
    J Clin Oncol; 1989 May; 7(5):554-6. PubMed ID: 2709085
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant endocrine therapy of breast cancer.
    Trudeau ME; Pritchard KI
    Cancer Treat Res; 1992; 60():69-114. PubMed ID: 1356002
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adjuvant therapy also in node-negative breast cancer?].
    Barth JA
    Zentralbl Gynakol; 1990; 112(2):57-9. PubMed ID: 2316296
    [No Abstract]   [Full Text] [Related]  

  • 11. Patterns of treatment failure--implications for new treatment approaches.
    Tattersall MH
    Recent Results Cancer Res; 1989; 115():1-7. PubMed ID: 2696022
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5.
    Jakesz R; Hausmaninger H; Kubista E; Gnant M; Menzel C; Bauernhofer T; Seifert M; Haider K; Mlineritsch B; Steindorfer P; Kwasny W; Fridrik M; Steger G; Wette V; Samonigg H;
    J Clin Oncol; 2002 Dec; 20(24):4621-7. PubMed ID: 12488405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvant therapy of breast cancer].
    Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
    Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
    [No Abstract]   [Full Text] [Related]  

  • 14. [Present status of endocrine therapy of breast cancer: a surgeon's view].
    Nomura Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):981-8. PubMed ID: 6426405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4-9 involved axillary lymph nodes.
    Bearman SI; Overmoyer BA; Bolwell BJ; Taylor CW; Shpall EJ; Cagnoni PJ; Mechling BE; Ronk B; Barón AE; Purdy MH; Ross M; Jones RB
    Bone Marrow Transplant; 1997 Dec; 20(11):931-7. PubMed ID: 9422471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant randomized trials of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF chemotherapy versus tamoxifen in women with node-positive breast cancer.
    Kaufmann M; Jonat W; Abel U; Hilfrich J; Caffier H; Kreienberg R; Trams G; Brunnert K; Schermann J; Kleine W
    J Clin Oncol; 1993 Mar; 11(3):454-60. PubMed ID: 8445420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adjuvant therapy in breast cancer].
    Semiglazov VF
    Vopr Onkol; 2000; 46(1):18-27. PubMed ID: 10789218
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis.
    Ludwig Breast Cancer Study Group
    Lancet; 1984 Jun; 1(8389):1256-60. PubMed ID: 6144974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in breast cancer chemo-endocrine therapy from the survival standpoint].
    Nomura Y
    Gan To Kagaku Ryoho; 1995 May; 22(6):726-31. PubMed ID: 7755380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment options for locally advanced breast cancer--experience in an Asian tertiary hospital.
    Chong HY; Taib NA; Rampal S; Saad M; Bustam AZ; Yip CH
    Asian Pac J Cancer Prev; 2010; 11(4):913-7. PubMed ID: 21133600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.